Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets

Por Barratt-Due, Andreas, Pischke, Søren Erik, Nilsson, Per H., Espevik, Terje, Mollnes, Tom Eirik
Publicado no J Leukoc Biol (2017)

Systemic CD14 Inhibition Attenuates Organ Inflammation in Porcine Escherichia coli Sepsis

Por Thorgersen, Ebbe Billmann, Pischke, Søren Erik, Barratt-Due, Andreas, Fure, Hilde, Lindstad, Julie Katrine, Pharo, Anne, Hellerud, Bernt Christian, Mollnes, Tom Eirik
Publicado em 2013